Table 1.
Data set | naa | npb | NM | PSAAc | |
---|---|---|---|---|---|
Latin Square | 42 | 248152 | PM | 0.17±0.009 | 0.184±0.010 |
248152 | MM | 0.40±0.009 | 0.416±0.009 | ||
Choe (Choe et al., 2005) | 6 | 195994 | PM | 0.20±0.022 | 0.216±0.025 |
195994 | MM | 0.46±0.017 | 0.49±0.017 | ||
Leukemia (Armstrong et al., 2002) | 72 | 201800 | PM | 0.49±0.063 | 0.51±0.062 |
201800 | MM | 0.60±0.036 | 0.61±0.035 | ||
Etoposide response (Fodor et al., 2006) | 60 | 496468 | PM | 0.05±0.040 | 0.06±0.040 |
496468 | MM | 0.11±0.062 | 0.12±0.062 | ||
BK knockout (Meredith et al., 2006;Pyott et al., 2006) | 20 | 496468 | PM | 0.09±0.035 | 0.10±0.036 |
496468 | MM | 0.29±0.050 | 0.30±0.049 | ||
Splicing microarray (Sugnet et al., 2006) | 75 | 505916 | PM | 0.30±0.062 | 0.31±0.063 |
Malaria (Le Roch et al., 2003) | 17 | 173262 | PM | 0.36±0.043 | 0.38±0.043 |
na: number of chips.
np: number of probes.
The differences in R2 between NM and PSAA are all statistically significant (P < 10-3) using paired one-sided Wilcoxon test.